Novogene Co., Ltd. (SHA:688315)
14.18
-0.29 (-2.00%)
Apr 21, 2026, 3:00 PM CST
Novogene Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,264 | 2,210 | 2,104 | 1,998 | 1,925 | 1,864 |
Other Revenue | - | - | 7.11 | 4.61 | 0.86 | 2.73 |
| 2,264 | 2,210 | 2,111 | 2,002 | 1,926 | 1,866 | |
Revenue Growth (YoY) | 5.56% | 4.66% | 5.46% | 3.97% | 3.17% | 25.26% |
Cost of Revenue | 1,290 | 1,270 | 1,194 | 1,150 | 1,077 | 1,072 |
Gross Profit | 974.41 | 939.76 | 917.55 | 852.43 | 849.07 | 793.9 |
Selling, General & Admin | 606.74 | 588.85 | 564.3 | 556.7 | 503.88 | 423.81 |
Research & Development | 166.48 | 159.93 | 131.45 | 124.18 | 125.57 | 145.29 |
Other Operating Expenses | -0.19 | -0.67 | 3.69 | -21.05 | -8.7 | -25.3 |
Operating Expenses | 773.02 | 748.12 | 721.99 | 675.46 | 648.03 | 563.57 |
Operating Income | 201.39 | 191.64 | 195.57 | 176.97 | 201.04 | 230.33 |
Interest Expense | - | - | -1.3 | -2.13 | -2.15 | -2.92 |
Interest & Investment Income | 19.84 | 21.69 | 31.41 | 27.47 | 11.89 | 8.27 |
Currency Exchange Gain (Loss) | - | - | 2.61 | 13.21 | 11.78 | -6.47 |
Other Non Operating Income (Expenses) | -39.15 | -34.46 | -0.94 | -2.31 | -4.36 | -2.72 |
EBT Excluding Unusual Items | 182.08 | 178.87 | 227.35 | 213.22 | 218.21 | 226.49 |
Gain (Loss) on Sale of Investments | 11.75 | 15.56 | 14.46 | -2.25 | -6.39 | 23.33 |
Gain (Loss) on Sale of Assets | 0.41 | 0.39 | -2.08 | -2.31 | -5.3 | -3.58 |
Asset Writedown | -1.91 | -1.91 | -9.15 | - | -8.46 | 0.03 |
Other Unusual Items | - | - | -5.86 | 3.98 | 10.51 | 0.18 |
Pretax Income | 192.33 | 192.91 | 224.73 | 212.63 | 208.56 | 246.46 |
Income Tax Expense | 24.87 | 21.43 | 20.89 | 29.41 | 27.02 | 17.58 |
Earnings From Continuing Operations | 167.46 | 171.48 | 203.84 | 183.22 | 181.53 | 228.89 |
Minority Interest in Earnings | -4.94 | -4.54 | -7.05 | -5.17 | -4.3 | -3.69 |
Net Income | 162.52 | 166.95 | 196.79 | 178.06 | 177.23 | 225.2 |
Net Income to Common | 162.52 | 166.95 | 196.79 | 178.06 | 177.23 | 225.2 |
Net Income Growth | -20.08% | -15.16% | 10.52% | 0.47% | -21.30% | 516.32% |
Shares Outstanding (Basic) | 407 | 407 | 410 | 405 | 403 | 387 |
Shares Outstanding (Diluted) | 407 | 407 | 410 | 405 | 403 | 387 |
Shares Change (YoY) | -2.81% | -0.68% | 1.31% | 0.47% | 4.14% | 5.86% |
EPS (Basic) | 0.40 | 0.41 | 0.48 | 0.44 | 0.44 | 0.58 |
EPS (Diluted) | 0.40 | 0.41 | 0.48 | 0.44 | 0.44 | 0.58 |
EPS Growth | -17.76% | -14.58% | 9.09% | - | -24.14% | 480.00% |
Free Cash Flow | 131.96 | 112.72 | 202.97 | 217.5 | 86.73 | 181.47 |
Free Cash Flow Per Share | 0.33 | 0.28 | 0.49 | 0.54 | 0.21 | 0.47 |
Dividend Per Share | - | - | 0.050 | 0.048 | 0.047 | 0.060 |
Dividend Growth | - | - | 5.26% | 1.06% | -21.67% | - |
Gross Margin | 43.04% | 42.53% | 43.46% | 42.58% | 44.09% | 42.54% |
Operating Margin | 8.89% | 8.67% | 9.26% | 8.84% | 10.44% | 12.34% |
Profit Margin | 7.18% | 7.56% | 9.32% | 8.89% | 9.20% | 12.07% |
Free Cash Flow Margin | 5.83% | 5.10% | 9.61% | 10.86% | 4.50% | 9.72% |
EBITDA | 328.86 | 320.12 | 328.13 | 304.4 | 313.1 | 347.24 |
EBITDA Margin | 14.52% | 14.49% | 15.54% | 15.20% | 16.26% | 18.61% |
D&A For EBITDA | 127.47 | 128.48 | 132.56 | 127.43 | 112.05 | 116.91 |
EBIT | 201.39 | 191.64 | 195.57 | 176.97 | 201.04 | 230.33 |
EBIT Margin | 8.89% | 8.67% | 9.26% | 8.84% | 10.44% | 12.34% |
Effective Tax Rate | 12.93% | 11.11% | 9.30% | 13.83% | 12.96% | 7.13% |
Revenue as Reported | - | - | 2,111 | 2,002 | 1,926 | 1,866 |
Advertising Expenses | - | - | 68.06 | 59.97 | 28.59 | 20.02 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.